GIA
EDIT icon

GHP Investment Advisors’s Editas Medicine EDIT Stock Holding History

GHP Investment Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-164
Closed -$191 – 970
2025
Q1 		$191 Buy
+164
New +$241 ﹤0.01% 932
2023
Q2 		– Sell
-200
Closed -$1.45K – 935
2023
Q1 		$1.45K Hold
200
– – ﹤0.01% 842
2022
Q4 		$1.77K Hold
200
– – ﹤0.01% 840
2022
Q3 		$2K Hold
200
– – ﹤0.01% 829
2022
Q2 		$2K Buy
+200
New +$2.68K ﹤0.01% 846

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GHP Investment Advisors's EDIT Position: Q2 2025 in Review

GHP Investment Advisors sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 164 shares — an estimated $191 sold.

GHP Investment Advisors first reported a position in EDIT in Q2 2022 and held it in 5 quarters. The position peaked at $2K in Q3 2022. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • GHP Investment Advisors reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • GHP Investment Advisors sold 164 Editas Medicine shares in Q2 2025, an estimated $191.
  • GHP Investment Advisors first reported a position in Editas Medicine in Q2 2022 and held it in 5 quarters.
  • GHP Investment Advisors's Editas Medicine position peaked at $2K in Q3 2022.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on GHP Investment Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.